Zimmer Biomet Holdings Net Income 2010-2023 | ZBH
Zimmer Biomet Holdings annual/quarterly net income history and growth rate from 2010 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- Zimmer Biomet Holdings net income for the quarter ending December 31, 2023 was $0.419B, a 421.72% decline year-over-year.
- Zimmer Biomet Holdings net income for the twelve months ending December 31, 2023 was $1.024B, a 342.52% increase year-over-year.
- Zimmer Biomet Holdings annual net income for 2023 was $1.024B, a 342.52% increase from 2022.
- Zimmer Biomet Holdings annual net income for 2022 was $0.231B, a 42.38% decline from 2021.
- Zimmer Biomet Holdings annual net income for 2021 was $0.402B, a 389.13% decline from 2020.
| Zimmer Biomet Holdings Annual Net Income (Millions of US $) |
|
|---|---|
| 2023 | $1,024 |
| 2022 | $231 |
| 2021 | $402 |
| 2020 | $-139 |
| 2019 | $1,132 |
| 2018 | $-379 |
| 2017 | $1,814 |
| 2016 | $306 |
| 2015 | $147 |
| 2014 | $720 |
| 2013 | $780 |
| 2012 | $755 |
| 2011 | $761 |
| 2010 | $597 |
| 2009 | $717 |
| Zimmer Biomet Holdings Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2023-12-31 | $419 |
| 2023-09-30 | $163 |
| 2023-06-30 | $210 |
| 2023-03-31 | $233 |
| 2022-12-31 | $-130 |
| 2022-09-30 | $194 |
| 2022-06-30 | $154 |
| 2022-03-31 | $14 |
| 2021-12-31 | $-85 |
| 2021-09-30 | $146 |
| 2021-06-30 | $142 |
| 2021-03-31 | $199 |
| 2020-12-31 | $334 |
| 2020-09-30 | $243 |
| 2020-06-30 | $-207 |
| 2020-03-31 | $-509 |
| 2019-12-31 | $321 |
| 2019-09-30 | $431 |
| 2019-06-30 | $134 |
| 2019-03-31 | $246 |
| 2018-12-31 | $-901 |
| 2018-09-30 | $162 |
| 2018-06-30 | $185 |
| 2018-03-31 | $175 |
| 2017-12-31 | $1,231 |
| 2017-09-30 | $99 |
| 2017-06-30 | $184 |
| 2017-03-31 | $299 |
| 2016-12-31 | $70 |
| 2016-09-30 | $159 |
| 2016-06-30 | $-31 |
| 2016-03-31 | $109 |
| 2015-12-31 | $127 |
| 2015-09-30 | $22 |
| 2015-06-30 | $-174 |
| 2015-03-31 | $171 |
| 2014-12-31 | $149 |
| 2014-09-30 | $173 |
| 2014-06-30 | $177 |
| 2014-03-31 | $222 |
| 2013-12-31 | $255 |
| 2013-09-30 | $154 |
| 2013-06-30 | $152 |
| 2013-03-31 | $219 |
| 2012-12-31 | $153 |
| 2012-09-30 | $178 |
| 2012-06-30 | $215 |
| 2012-03-31 | $210 |
| 2011-12-31 | $157 |
| 2011-09-30 | $192 |
| 2011-06-30 | $204 |
| 2011-03-31 | $209 |
| 2010-12-31 | $35 |
| 2010-09-30 | $191 |
| 2010-06-30 | $166 |
| 2010-03-31 | $205 |
| 2009-12-31 | $155 |
| 2009-09-30 | $150 |
| 2009-06-30 | $210 |
| 2009-03-31 | $202 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $24.522B | $7.394B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $186.584B | 24.49 |
| Stryker (SYK) | United States | $127.690B | 31.66 |
| Boston Scientific (BSX) | United States | $107.347B | 34.19 |
| Medtronic (MDT) | Ireland | $105.881B | 14.99 |
| EssilorLuxottica (ESLOY) | France | $98.566B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.036B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.584B | 30.18 |
| ResMed (RMD) | United States | $32.074B | 30.08 |
| Terumo (TRUMY) | Japan | $24.746B | 34.95 |
| Baxter (BAX) | United States | $20.379B | 14.86 |
| Koninklijke Philips (PHG) | Netherlands | $19.567B | 15.61 |
| Insulet (PODD) | United States | $11.637B | 61.10 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.689B | 0.00 |
| Demant (WILYY) | Denmark | $9.943B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.869B | 23.44 |
| BellRing Brands (BRBR) | United States | $7.379B | 39.68 |
| Haemonetics (HAE) | United States | $4.621B | 23.63 |
| Lantheus Holdings (LNTH) | United States | $4.494B | 11.60 |
| Perrigo (PRGO) | Ireland | $4.328B | 12.38 |
| GN Store Nord (GNNDY) | Denmark | $4.065B | 26.32 |
| Envista Holdings (NVST) | United States | $3.504B | 13.33 |
| Prestige Consumer Healthcare (PBH) | United States | $3.499B | 16.54 |
| QuidelOrtho (QDEL) | United States | $2.651B | 9.62 |
| Neogen (NEOG) | United States | $2.630B | 25.29 |
| Green Thumb Industries (GTBIF) | United States | $2.571B | 81.47 |
| ICU Medical (ICUI) | United States | $2.311B | 17.24 |
| TG Therapeutics (TGTX) | United States | $2.082B | 673.50 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.936B | 0.00 |
| Owens & Minor (OMI) | United States | $1.922B | 18.45 |
| Agios Pharmaceuticals (AGIO) | United States | $1.770B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.697B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.469B | 48.49 |
| InMode (INMD) | Israel | $1.439B | 7.45 |
| National Vision Holdings (EYE) | United States | $1.400B | 43.61 |
| AdaptHealth (AHCO) | United States | $1.324B | 9.96 |
| Warby Parker (WRBY) | United States | $1.271B | 0.00 |
| AtriCure (ATRC) | United States | $1.121B | 0.00 |
| MacroGenics (MGNX) | United States | $0.911B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.893B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.794B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.709B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.682B | 14.73 |
| Evolus (EOLS) | United States | $0.662B | 0.00 |
| Jin Medical (ZJYL) | China | $0.626B | 0.00 |
| Quanterix (QTRX) | United States | $0.595B | 0.00 |
| Valneva SE (VALN) | France | $0.532B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.516B | 11.17 |
| PetIQ (PETQ) | United States | $0.486B | 18.16 |
| TerrAscend (TSNDF) | Canada | $0.486B | 0.00 |
| ZimVie (ZIMV) | United States | $0.431B | 26.37 |
| Biote (BTMD) | United States | $0.411B | 3.91 |
| OraSure Technologies (OSUR) | United States | $0.407B | 6.73 |
| Surmodics (SRDX) | United States | $0.373B | 40.26 |
| Aurora Cannabis (ACB) | Canada | $0.365B | 0.00 |
| Zynex (ZYXI) | United States | $0.361B | 41.52 |
| Viemed Healthcare (VMD) | United States | $0.322B | 31.96 |
| Cerus (CERS) | United States | $0.310B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.279B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.250B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.237B | 14.65 |
| Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
| Veru (VERU) | United States | $0.186B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.183B | 0.00 |
| Omeros (OMER) | United States | $0.183B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.170B | 0.00 |
| High Tide (HITI) | Canada | $0.161B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.156B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.144B | 72.36 |
| FitLife Brands (FTLF) | United States | $0.132B | 21.28 |
| Jushi Holdings (JUSHF) | United States | $0.131B | 0.00 |
| InterCure (INCR) | Israel | $0.121B | 20.46 |
| Fonar (FONR) | United States | $0.103B | 8.84 |
| MariMed (MRMD) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.092B | 0.00 |
| Safety Shot (SHOT) | United States | $0.082B | 0.00 |
| Chimerix (CMRX) | United States | $0.080B | 0.00 |
| Brainsway (BWAY) | Israel | $0.079B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.058B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.054B | 3.53 |
| Apyx Medical (APYX) | United States | $0.050B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.77 |
| Bright Green (BGXX) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Agape ATP (ATPC) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 71.82 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |